In-hospital Stellate Ganglion Block for Arrhythmic Storm
Launched by FONDAZIONE IRCCS POLICLINICO SAN MATTEO DI PAVIA · Jan 31, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment for a serious condition called arrhythmic storm, which involves having multiple dangerous heart rhythms in a short period of time. The trial is looking at a procedure called Percutaneous Stellate Ganglion Block (PSGB), which involves injecting medication near certain nerves in the neck to help control these irregular heartbeats. Participants in the trial will be people aged 18 and older who have experienced more than three episodes of these heart rhythms in a day that haven't responded to regular medications.
If you qualify and decide to participate, you will receive the PSGB treatment while in the hospital. The doctors will monitor how many times defibrillation (a treatment to restore a normal heart rhythm) is needed before and after the PSGB to see if it is effective. The study will also keep track of any complications that might arise from the procedure. You can choose between two approaches for the injection, with the doctor deciding the best method based on your situation. This trial is currently recruiting participants, and it’s open to anyone who meets the eligibility criteria, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 18 years,
- • presence of arrhythmic storm defined as more than three sustained ventricular arrhythmias in 24 hours refractory to the standard medical treatment.
- Exclusion Criteria:
- • A previous history of cardiac sympathicectomy
- • Having a neck judged unsuitable for the procedure (previous neck surgery, previous burns, presence of large scars, thyroid goiter)
- Both the two approaches present in literature and commonly used for this technique are allowed for the study:
- • The "anatomical" approach which consist in the identification of the Chassaignac's tubercle that represents the point of needle insertion
- • The "echo-guided" approach Regardless to the approach (anatomical or echo-guided) the doctor will be able to choose, according to the clinical characteristics of the patients, whether to perform a single shot injection of anesthetic or a continuous infusion of anesthetic. In the second case a catheter will be left in place and connected to an infusion pump.
About Fondazione Irccs Policlinico San Matteo Di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia is a prestigious research hospital and clinical trial sponsor located in Italy, dedicated to advancing medical knowledge and improving patient care through innovative research. As a leading institution in the fields of clinical and translational medicine, the foundation actively conducts trials across various therapeutic areas, emphasizing rigorous scientific methodologies and adherence to ethical standards. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, Fondazione IRCCS Policlinico San Matteo serves as a pivotal contributor to the development of new treatments and healthcare solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Asti, , Italy
Savona, , Italy
Milan, , Italy
Pavia, Pv, Italy
Firenze, , Italy
Milan, , Italy
Novara, , Italy
Milan, , Italy
Padova, , Italy
Lecco, , Italy
Lugano, , Switzerland
Alessandria, Al, Italy
Bologna, Bo, Italy
Cagliari, , Italy
Castellanza, , Italy
Domodossola, , Italy
Grosseto, , Italy
Messina, , Italy
Milano, , Italy
Perugia, , Italy
Roma, , Italy
Roma, , Italy
Torino, , Italy
Verona, , Italy
Bentivoglio, Bo, Italy
Pavia, Pv, Italy
Voghera, Pv, Italy
Legnago, Vr, Italy
Ancona, , Italy
Bologna, , Italy
Crema, , Italy
Firenze, , Italy
Gubbio, , Italy
Ivrea, , Italy
Livorno, , Italy
Napoli, , Italy
Rimini, , Italy
Roma, , Italy
Roma, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials